BlijWerkt has been acquired by Mentha Capital
Gilde Healthcare Partners has sold BlijWerkt Groep B.V. to Mentha Capital.
BlijWerkt is a Dutch provider of occupational health services that help companies manage employee absenteeism. The firm reduces the costs of absenteeism by increasing the vitality of client organizations and their employees. It also manages the process of sick leave and reintegration. BlijWerkt combines the power of the bigger players with the flexibility and personal attention of the smaller ones. The company is headquartered in Woerden, the Netherlands and is owned by Gilde Healthcare Partners, a Dutch private equity investor, since 2011. BlijWerkt has a diversified client base and is mainly active in the healthcare, government and educational sectors. The Group’s solutions are a high impact, mandatory service of negligible cost to its clients, which results in recurring revenues of +95%.
Mentha Capital is an independent investment company that focuses on the lower-end of the mid-market in the Benelux. Mentha invests in established, medium-sized and profitable companies that have the opportunity to grow further through a buy-and-build strategy, expansion into new markets or an organizational transition. With more than €400 million under management, Mentha works actively with entrepreneurs to support their companies in realizing their ambitious growth plans.
Gilde Healthcare is a specialized European healthcare investor managing €1 billion across two fund strategies: venture and growth capital and private equity. Gilde Healthcare's venture and growth capital fund invests in health tech and therapeutics. The venture and growth companies are based in Europe and North America. Gilde Healthcare's private equity fund invests in profitable European lower mid-market healthcare companies with a focus on the Benelux and DACH region. The private equity fund targets healthcare providers, suppliers of medical products and service providers in the healthcare market.
Oaklins’ team in the Netherlands acted as the exclusive M&A advisor to the shareholders of BlijWerkt Groep B.V., including the majority shareholder Gilde Healthcare Partners.
Hugo de Bruin
Partner, Gilde Healthcare Partners
Talk to the deal team
Frederik van der Schoot
Managing PartnerAmsterdam, Netherlands
Felix Snoeck Henkemans
Permali Gloucester has been acquired by Diamorph (subject to regulatory approval)
Private equity firm 3i Group and the private shareholders of Permali Gloucester Limited have sold their interest in the company to Diamorph.Learn more
Westiform, ID Néon and Nicklex merge to form WIN Group
The shareholders of Westiform Group have sold their shares to WIN Group, a newly created entity owned by the Hofmann family and consisting of ID Néon and Nicklex, two major players in the visual communication market in Switzerland.Learn more
BaltCap has sold Labochema to French laboratory supply distributor Dominique Dutscher
BaltCap Lithuania SME Fund has sold its 46% shareholding in Labochema UAB, a Lithuanian laboratory supplies trading company, to Dominique Dutscher. Labochema’s CEO and the chairman also sold their shareholdings. As a result of the transaction, Dominique Dutscher now controls 100% of Labochema.Learn more